Nitric Oxide

Manufacturer
HumanEnos LLC
Effective date
2023-02-18
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:36:20

Label at a glance#

ProductDr. GNO Recovery Oil (Brightening, Wrinckle care, and Moisturizing effect, Acne Treatment, Fermented Cabbage Extract)
Active ingredientNITRIC OXIDE
Label structure8 sections

Label contents#

Full prescribing information#

DOSAGE & ADMINISTRATION SECTION

Dr.GN:O Recovery Oil

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Warnings

INDICATIONS & USAGE SECTION

Dr.GN:O Recovery Oil

WARNINGS SECTION

Warnings

OTC - PURPOSE SECTION

Dr.GN:O Recovery Oil

INACTIVE INGREDIENT SECTION

Inactive ingredients:

Olive oil, Rose oil, Sunflower seed oil

OTC - ACTIVE INGREDIENT SECTION

Active ingredients:

Nitric Oxide

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

2424

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83202-771583202-7715-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
NITRIC OXIDE31C4KY9ESHACTIB
OLIVE OIL6UYK2W1W1EIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f517174e-4123-0d2d-e053-2a95a90a8c04f517174e-4122-0d2d-e053-2a95a90a8c042023-02-18WarningsExact identifier
spl id: f517174e-4123-0d2d-e053-2a95a90a8c04
spl set id: f517174e-4122-0d2d-e053-2a95a90a8c04

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.